- Home
- GDEN vs EVMN Comparison
GDEN vs EVMN Comparison
Compare GDEN & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDEN | EVMN |
|---|---|---|
| Founded | 1998 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 741.2M | 628.9M |
| IPO Year | 1999 | 2025 |
Fundamental Metrics
Financial Performance| Metric | GDEN | EVMN |
|---|---|---|
| Price | $27.92 | $14.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $32.20 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 307.0K | 119.1K |
| Earning Date | 11-06-2025 | 12-11-2025 |
| Dividend Yield | ★ 3.60% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $643,485,000.00 | $13,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.97 | N/A |
| P/E Ratio | $136.33 | ★ N/A |
| Revenue Growth | N/A | ★ 160.00 |
| 52 Week Low | $19.57 | $15.43 |
| 52 Week High | $35.49 | $24.03 |
Technical Indicators
Market Signals| Indicator | GDEN | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 50.00 | N/A |
| Support Level | $27.72 | N/A |
| Resistance Level | $28.70 | N/A |
| Average True Range (ATR) | 0.55 | 0.00 |
| MACD | -0.28 | 0.00 |
| Stochastic Oscillator | 4.35 | 0.00 |
Price Performance
Historical ComparisonAbout GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.